1-2 of 2
Said Y Mohamad, MD
Close
Sort by
Journal Articles

Real-World Data Indicates That the Addition of Etoposide to Idarubicin and Cytarabine (3+7) Induction in Young Adults (<60 years) with AML Does Not Improve Survival or Remission Rates

Syed Osman Ahmed, MRCP, FRCPath, Fahad Almohareb, Mahmoud Aljurf, MD MPH, Modhi Alhussinan, Dalal Bawazeer, Hazza A Alzahrani, MD, Fahad Z. Alsharif, MBChB, MD, Said Y Mohamad, MD, Amr Hanbali, MD, Feras Alfraih, MD, Marwan Shaheen, MD, Riad O. El Fakih, MD, Shahrukh Hashmi, MD MPH, Muhamad Hitham Almahayni, MD MRCP, Ali Al Ahmari, Shad Ahmed, Wahiba Chebbo, Ahmad Salih Alotaibi, MD, Abdul Mannan, Ghada el Gohary, Osama Ali, Maamoun Alsermani, MD MRCP,, Farhan Anjum, Ghada Aljuhani, Fazal Hussain, Naeem A. Chaudhri, MD FACP, Walid Rasheed, MD
Journal: Blood
Blood (2016) 128 (22): 4010.
https://doi.org/10.1182/blood.V128.22.4010.4010
Published: 2016
Journal Articles

Young Adult Patients with Post -HCT Relapse of AML May Benefit from Aggressive Salvage and 2 nd Cellular Therapy

Syed Osman Ahmed, MRCP, FRCPath, Amna Gamil, MD, Muhamad Hitham Almahayni, MD MRCP,, Naeem A. Chaudhri, MD FACP, Fahad Alsharif, MD, Said Y Mohamad, MD, Hazza A Alzahrani, MD, Walid Rasheed, MD, Ghuzayel Aldawsari, MD, Amr Hanbali, MD, Marwan Shaheen, MD, Feras Alfraih, MD, Shad Ahmed, MD, Khaled Ibrahim, Fahed Almhareb, MD, Mahmoud Aljurf, MD MPH
Journal: Blood
Blood (2015) 126 (23): 5482.
https://doi.org/10.1182/blood.V126.23.5482.5482
Published: 2015